JPMorgan reduces its holdings in GENSCRIPT BIO (01548) by approximately 33.751 million shares at approximately HK$32.74 per share.
On September 15, JPMorgan reduced its holdings in GenScript Biotech (01548) by 33.751017 million shares at HK$32.7394 per share, for a total amount of approximately HK$1.105 billion.
The latest information from the Hong Kong Stock Exchange shows that on September 15, JPMorgan reduced its holdings in GENSCRIPT BIO (01548) by 33.751017 million shares at HK$32.7394 per share, for a total amount of approximately HK$1.105 billion. After the reduction, its latest shareholding is approximately 129 million shares, with its latest shareholding ratio at 5.64%.
Related Articles
TIAN TU CAPITAL (01973) will distribute an interim dividend of HK$1.738755 per 10 shares on November 9.
Sunward Intelligent Equipment (002097.SZ) shareholders and senior executives plan to collectively reduce their holdings by no more than 1.03% of shares.
NEWLINK TECH (09600) terminates acquisition of HK Ant Global Investment Co., Limited
TIAN TU CAPITAL (01973) will distribute an interim dividend of HK$1.738755 per 10 shares on November 9.
Sunward Intelligent Equipment (002097.SZ) shareholders and senior executives plan to collectively reduce their holdings by no more than 1.03% of shares.
NEWLINK TECH (09600) terminates acquisition of HK Ant Global Investment Co., Limited
RECOMMEND
